<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01881646</url>
  </required_header>
  <id_info>
    <org_study_id>POPE</org_study_id>
    <nct_id>NCT01881646</nct_id>
  </id_info>
  <brief_title>Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery</brief_title>
  <acronym>POPE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to assess the induction of neuroinflammation in brain
      regions of interest for learning and memory in adult patients undergoing urological surgery
      under general anesthesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to study immune cell activation as a biomarker for neuroinflammation
      using the cell specific [11C]PBR28 probe as detected by PET imaging techniques.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Binding of the PET probe [11C]PBR28</measure>
    <time_frame>Preoperatively, once at postoperative day 2-5 and after 3 month</time_frame>
    <description>PET imaging of brain regions of relevance for memory and learning will be compared between the pre- and postoperative states.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive testing</measure>
    <time_frame>Preoperatively and after 3 month</time_frame>
    <description>Postoperative cognitive test battery according to the ISPOCD protocol, see Moller JT et al, Lancet 1998.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory biomarkers</measure>
    <time_frame>Preoperatively, once at postoperative day 2-5 and after 3 month, i.e. at the same time as the PET investigation</time_frame>
    <description>Inflammatory biomarkers and genetic analysis of inflammatory biomarkers in blood.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Anesthesia</condition>
  <condition>Surgery</condition>
  <condition>Neurogenic Inflammation</condition>
  <condition>Cognitive Disorders</condition>
  <arm_group>
    <arm_group_label>Positron emission tomography (PET)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Positron emission tomography (PET) using [11C]PBR28</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Positron emission tomography (PET) using [11C]PBR28</intervention_name>
    <arm_group_label>Positron emission tomography (PET)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients 60-75 years of age. American Society for Anesthesiologist' criteria (ASA)
             physical status I-III

          2. Lower abdominal surgery (hysterectomy/prostatectomy) under general anaesthesia

          3. Obtained consent within 3 months before execution of the study.

        Exclusion Criteria:

          1. Patient's refusal to participate in the trial

          2. Ongoing smoking, snuff or other nicotine compound treatment

          3. Disabling neuropsychiatrical disorder (a Mini mental State Examination (MMSE) score â‰¤
             24, diagnosis of dementia, Mb Alzheimer, Mb Parkinson, schizophrenia, or mental
             depression) or other signs of significant cognitive decline.

          4. History of stroke with neurological sequelae

          5. Surgical procedure scheduled for regional anaesthesia.

          6. Severe cardia and/or renal and/or hepatic impairment.

          7. Coagulopathy.

          8. Terminal phase of a chronic disease.

          9. Patient on steroidal or non-steroidal anti-inflammatory drugs.

         10. Admission B-Glucose &gt; 15 mmol/litre or poorly controlled diabetes mellitus.

         11. Presumed uncooperativeness or legal incapacity.

         12. Preoperative or later postoperative B-hemoglobin &lt; 90 g/L.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars I Eriksson, MD,PhD, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital and Karolinska Institutet</affiliation>
  </overall_official>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2013</study_first_posted>
  <last_update_submitted>January 10, 2017</last_update_submitted>
  <last_update_submitted_qc>January 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Lars I Eriksson</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Neuroinflammation</keyword>
  <keyword>Postoperative cognitive dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
    <mesh_term>Neurogenic Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

